Search research articles
Contact Us
Filters
Showing results (151-160 of 331) with videos related to
Page
of 34
Sort By:
European Urology Focus
|
September 19, 2017
Treatment Patterns and Survival Outcomes for Patients with Small Cell Carcinoma of the Bladder
Benjamin W Fischer-Valuck, Yuan James Rao, Lauren E Henke, et al.
Brachytherapy
|
May 31, 2022
Assessing the impact of brachytherapy boost and androgen deprivation therapy on survival outcomes for patients with unfavorable intermediate-risk prostate cancer patients treated with external beam radiotherapy
Neal Andruska, Temitope Agabalogun, Benjamin W Fischer-Valuck, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 1995
The Electronic View Box: a software tool for radiation therapy treatment verification
W R Bosch, D A Low, R L Gerber, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 12, 2010
A phase I/II radiation dose escalation study with concurrent chemotherapy for patients with inoperable stages I to III non-small-cell lung cancer: phase I results of RTOG 0117
Jeffrey D Bradley, Jennifer Moughan, Mary V Graham, et al.
Clinical and Experimental Immunology
|
December 26, 2015
Activation of the lectin pathway of complement by cardiopulmonary bypass contributes to the development of systemic inflammatory response syndrome after paediatric cardiac surgery
I Pągowska-Klimek, A S Świerzko, M Michalski, et al.
Clinical Genitourinary Cancer
|
January 28, 2022
Propensity-Weighted Survival Analysis of SBRT vs. Conventional Radiotherapy in Unfavorable Intermediate-Risk Prostate Cancer
Neal Andruska, Benjamin W Fischer-Valuck, Temitope Agabalogun, et al.
Frontiers in Oncology
|
October 17, 2019
Abscopal Effect Following Proton Beam Radiotherapy in a Patient With Inoperable Metastatic Retroperitoneal Sarcoma
Randall J Brenneman, Nima Sharifai, Benjamin Fischer-Valuck, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 8, 2011
Estimation of α/β for late rectal toxicity based on RTOG 94-06
Susan L Tucker, Howard D Thames, Jeff M Michalski, et al.
Journal of Applied Clinical Medical Physics
|
January 13, 2023
Logistical, technical, and radiation safety aspects of establishing a radiopharmaceutical therapy program: A case in Lutetium-177 prostate-specific membrane antigen (PSMA) therapy
Jacqueline E Zoberi, Jose Garcia-Ramirez, David Luechtefeld, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 7, 2010
Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117
Jeffrey D Bradley, Kyounghwa Bae, Mary V Graham, et al.
Page
of 34
Search research articles
Search
Showing results (151-160 of 331) with videos related to
Sort By:
Page
of 34
European Urology Focus
|
September 19, 2017
Treatment Patterns and Survival Outcomes for Patients with Small Cell Carcinoma of the Bladder
Benjamin W Fischer-Valuck, Yuan James Rao, Lauren E Henke, et al.
Brachytherapy
|
May 31, 2022
Assessing the impact of brachytherapy boost and androgen deprivation therapy on survival outcomes for patients with unfavorable intermediate-risk prostate cancer patients treated with external beam radiotherapy
Neal Andruska, Temitope Agabalogun, Benjamin W Fischer-Valuck, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 1995
The Electronic View Box: a software tool for radiation therapy treatment verification
W R Bosch, D A Low, R L Gerber, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 12, 2010
A phase I/II radiation dose escalation study with concurrent chemotherapy for patients with inoperable stages I to III non-small-cell lung cancer: phase I results of RTOG 0117
Jeffrey D Bradley, Jennifer Moughan, Mary V Graham, et al.
Clinical and Experimental Immunology
|
December 26, 2015
Activation of the lectin pathway of complement by cardiopulmonary bypass contributes to the development of systemic inflammatory response syndrome after paediatric cardiac surgery
I Pągowska-Klimek, A S Świerzko, M Michalski, et al.
Clinical Genitourinary Cancer
|
January 28, 2022
Propensity-Weighted Survival Analysis of SBRT vs. Conventional Radiotherapy in Unfavorable Intermediate-Risk Prostate Cancer
Neal Andruska, Benjamin W Fischer-Valuck, Temitope Agabalogun, et al.
Frontiers in Oncology
|
October 17, 2019
Abscopal Effect Following Proton Beam Radiotherapy in a Patient With Inoperable Metastatic Retroperitoneal Sarcoma
Randall J Brenneman, Nima Sharifai, Benjamin Fischer-Valuck, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 8, 2011
Estimation of α/β for late rectal toxicity based on RTOG 94-06
Susan L Tucker, Howard D Thames, Jeff M Michalski, et al.
Journal of Applied Clinical Medical Physics
|
January 13, 2023
Logistical, technical, and radiation safety aspects of establishing a radiopharmaceutical therapy program: A case in Lutetium-177 prostate-specific membrane antigen (PSMA) therapy
Jacqueline E Zoberi, Jose Garcia-Ramirez, David Luechtefeld, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 7, 2010
Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117
Jeffrey D Bradley, Kyounghwa Bae, Mary V Graham, et al.
Page
of 34